Проблемы метаболического синдрома и его комп онентов в современном мире

The last decade has been characterized by a significant increase in the number of patients with metabolic syndrome, which remains a global public health problem and a leading risk factor for cardiovascular and noncommunicable diseases. MS is characterized by an increase in the mass of visceral fat, a decrease in the sensitivity of peripheral tissues to insulin by hyperinsulinemia causing the development of combined pathology of internal diseases disorders of carbohydrate, lipid, purine metabolism and arterial hypertension.